Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Laser hair removal works well for people with dark hair and light skin, but it's less effective for light hair or dark skin; improvements are expected.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Substance from human umbilical cord blood cells promotes hair growth.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some chemicals absorbed through the skin can cause serious health problems.

Newer skin resurfacing lasers reduce damage and scarring, with some approved for safe use and minimal side effects.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.